CHU Clermont-Ferrand
Clermont-Ferrand, France
Location status: Recruiting
NCT Number: NCT07278583
CARDIAUVERGNE is a heart failure telemonitoring system at Clermont-Ferrand's hospital. The aim of this study is to analyze the prognosis and evolution of patients after exclusion of telemonitoring. The patients were included from 1st January 2023 to 31st December 2024 and the monitoring was terminated for end of eligibility according to the French health authority criteria.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Clermont-Ferrand, France
Location status: Recruiting
After an episode of heart failure, patients have been included in a telemonitoring program in order to reduce rehospitalizations for heart failure and improve follow-up. On a daily basis, the patients weigh themselves on connected scales which enables a team of dedicated nurses to follow them closely. If need be they can call the patient, ask for a blood exam and adapt their prescription. Indeed, if remote support is insufficient, patients can be hospitalized prematurely and so decrease the duration of hospital care.
The inclusion criteria correspond to either an episode of heart failure in the last 12 months or dyspnea at least New York Heart Association (NYHA) 2 with NT-proBNP over 1000pg/mL.
The follow up is renewed every 6 months. Patients are excluded from monitoring when criteria are no longer fulfilled. As these characteristics have been chosen empirically, our aim is to see if patients no longer presenting these standards have indeed a low chance of bad evolution.
Information is gathered from their medical record at inclusion, exclusion and 1 year after exclusion. A short phone call is made after 1 year of exclusion, to appreciate their evolution and gather information concerning their symptoms, treatments ...
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: From telemonitoring exclusion up to a year after
Time frame: From telemonitoring exclusion up to a year after
General practician and cardiology consultations
Time frame: From inclusion until a year after exclusion
NTproBNP comparison at inclusion, exclusion and a year after exclusion for monitoring
Time frame: From telemonitoring exclusion up to a year after
Time frame: From inclusion up to a year after telemonitoring exclusion
Contact information is provided by the study sponsor or research team.
University Hospital, Clermont-Ferrand
Other
Evaluation of Eligibility Criteria for Heart Failure Telemonitoring : Analysis of CARDIAUVERGNE's Cohort
Acronym: Weigh-HF
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07581587
Cardiovascular Diseases, Heart Diseases
Istanbul, Fatih, Turkey (Türkiye)
View Trial DetailsNCT07492524
Arrhythmias, Cardiac, Atrial Fibrillation
Yancheng, Dongtai, China
View Trial DetailsNCT07482943
Cardiovascular Abnormalities, Cardiovascular Diseases
Hong Kong
View Trial DetailsNCT07701369
Cardiovascular Diseases, Heart Diseases
Paris, France
View Trial Details